PWPaul I. J. M. Wuisman

Paul I. J. M. Wuisman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul I. J. M. Wuisman has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Theo H. Smit

    From the *Department of Orthopaedic Surgery, VU University Medical Center (VUmc), Amsterdam; †TNO Quality of Life, Biomedical Research, Department of Tissue Repair, Leiden; ‡Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), Universiteit van Amsterdam and Vrije Universiteit Amsterdam; §Department of Physics and Medical Technology, VUmc, Amsterdam; and ¶Skeletal Tissue Engineering Group Amsterdam (STEGA), The Netherlands

    5 shared publications
  • Christopher Faber

    Department of Orthopaedic Surgery, VU University Medical Center, P. O. Box 7057, 1007 MB Amsterdam, The Netherlands

    4 shared publications
  • Hein P. Stallmann

    Department of Orthopaedic Surgery, VU University Medical Center, Amsterdam, The Netherlands,1 Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam, University of Amsterdam, and Vrije Universiteit, Amsterdam, The Netherlands,2 Department of Trauma and Hand Surgery, Marienhospital, Osnabrück,3 Institute of Medical Microbiology, University of Münster, Münster, Germany,4 Department of Oral Biochemistry, ACTA, Boechorststraat 7, 1081 BT Amsterdam, The Netherlands5

    3 shared publications
  • Antonius L. J. J. Bronckers

    2 shared publications
  • Arie V. Nieuw Amerongen

    2 shared publications
  • D. M. Lyaruu

    Department of Orthopaedic Surgery, VU University Medical Center, Amsterdam, The Netherlands,1 Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam, University of Amsterdam, and Vrije Universiteit, Amsterdam, The Netherlands,2 Department of Trauma and Hand Surgery, Marienhospital, Osnabrück,3 Institute of Medical Microbiology, University of Münster, Münster, Germany,4 Department of Oral Biochemistry, ACTA, Boechorststraat 7, 1081 BT Amsterdam, The Netherlands5

    2 shared publications

Latest Publications

  • Adjacent Segment Degeneration

    by Roel J. W. Hoogendoorn, Macro N. Helder, Paul I. J. M. Wuisman, Ruud A. Bank, Vincent E. Everts, Theo H. Smit

    Study Design. The adjacent discs of 13 goats, originally used in a lumbar spinal fusion model study, were analyzed for symptoms of intervertebral disc degeneration by means of magnetic resonance imaging (MRI), macroscopy, and histology. These goats were followed for 6 months and the results were compared with 6 control goats. Objective. To evaluate the development of adjacent segment disc degeneration in vivo in a goat lumbar spinal fusion model. Summary of Background Data. There is ongoing debate on whether adjacent segment degeneration (ASD) develops through increased biomechanical load on discs adjacent to fusion sites, or by the natural process of pre-existing degenerative disease. Animal models offer an opportunity to separate these factors by evaluating the development of ASD in nondegenerated animal spines. Methods. In a spinal fusion model study 2 segments (L3-L4 and L1-L2) were fixated and followed for 3 months (n = 6) and 6 months (n = 7) in 13 skeletally mature goats. Two adjacent discs (T13-L1 and L4-L5), 1 interjacent disc (L2-L3) and a control disc (L5-L6) were analyzed by means of magnetic resonance imaging, macroscopy, and histology. These results were compared with the discs of 6, nonoperated “normal” goats. Results. No differences were observed in the adjacent and interjacent intervertebral discs after both follow-up periods. However, severe degenerative changes were observed in the L5-L6 level, originally included as controls. Conclusion. Large animal fusion models offer an excellent opportunity to study ASD in vivo, as pre-existing degenerative disc disease is not present and biomechanical effects of the fusion can be studied more isolated. Our results suggest that adjacent disc degeneration does not develop in our spinal goat fusion model. There is, however, an increased risk of disc degeneration in the L5-L6 level through an unclear mechanism.


  • Reproducible Long-term Disc Degeneration in a Large Animal Model

    by Roel J. W. Hoogendoorn, Marco N. Helder, Robert Jan Kroeze, Ruud A. Bank, Theo H. Smit, Paul I. J. M. Wuisman

    Study Design. Twelve goats were chemically degenerated and the development of the degenerative signs was followed for 26 weeks to evaluate the progression of the induced degeneration. The results were also compared with a previous study to determine the reproducibility. Objectives. The purpose of this study was determine whether this Chondroitinase ABC (CABC) induced goat model is reproducible and to study the development of the degeneration in time up to 26 weeks. Summary of Background Data. Injecting CABC into goat intervertebral discs results in mild disc degeneration after 12 weeks. Spontaneous recovery or leveling off of the degeneration has been reported before and is relevant when the goat model is used in regeneration studies. Reproducibility of the induced degeneration is relevant as well. Methods. Twelve goats were used in this study. The development of degeneration was studied after the injection of 0.25 U/mL CABC intradiscally. The development of degenerative signs was studied after 18 (n = 6) and 26 (n = 6) weeks by means of radiograph, magnetic resonance imaging, macroscopic analysis, and histology and biochemical evaluation. The induced degeneration was compared with the results from a previous study, in which degeneration was induced similarly and analysis was performed after 12 weeks. Results. The severity of the degenerative signs was mild and was consequently present in all parameters analyzed. When compared with the results after 12 weeks, the degeneration was similar in the present study. Spontaneous recovery was not observed up to 26 weeks. Conclusion. The injection with CABC in the intervertebral disc reproducibly results in mild disc degeneration in the goat. These findings corroborate the goat model as a suitable large animal model to evaluate mild disc degeneration and potential new therapies.


  • Open Access

    Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases

    by Harm Ca Graat, Victor W van Beusechem, Frederik He Schagen, M Adhiambo Witlox, Eugenie S Kleinerman, Marco N Helder, Winald R Gerritsen, Gertjan Jl Kaspers, Paul Ijm Wuisman

    Metastatic osteosarcoma (OS) has a very poor prognosis. New treatments are therefore wanted. The conditionally replicative adenovirus Ad5-Δ24RGD has shown promising anti-tumor effects on local cancers, including OS. The purpose of this study was to determine whether intravenous administration of Ad5-Δ24RGD could suppress growth of human OS lung metastases. Mice bearing SaOs-lm7 OS lung metastases were treated with Ad5-Δ24RGD at weeks 1, 2 and 3 or weeks 5, 6 and 7 after tumor cell injection. Virus treatment at weeks 1–3 did not cause a statistically significant effect on lung weight and total body weight. However, the number of macroscopic lung tumor nodules was reduced from a median of >158 in PBS-treated control mice to 58 in Ad5-Δ24RGD-treated mice (p = 0.15). Moreover, mice treated at weeks 5–7 showed a significantly reduced lung weight (decrease of tumor mass, p < 0.05), a significantly increased body weight gain (decrease of disease symptoms, p < 0.005) and a reduced number of macroscopic lung tumor nodules (median 60 versus > 149, p = 0.12) compared to PBS treated control animals. Adenovirus hexon expression was detected in lung tumor nodules at sacrifice three weeks after the last intravenous adenovirus administration, suggesting ongoing viral infection. These findings suggest that systemic administration of Ad5-Δ24RGD might be a promising new treatment strategy for metastatic osteosarcoma.


  • Open Access

    Effect of long-term preservation on the mechanical properties of cortical bone in goats

    by Emil H van Haaren, Babette C van der Zwaard, Albert J van der Veen, Ide C Heyligers, Paul Ijm Wuisman, Theo H Smit

    Background and purpose Bones used in mechanical studies are frequently harvested from human cadavers that have been embalmed in a buffered formaldehyde solution. It has been reported that formaldehyde fixation or freezing hardly affects the mechanical properties of bone after a storage period of several weeks. However, human cadaver bones are usually stored for longer periods of time before use. We therefore investigated the effects of long-term embalming or freezing on the mechanical properties of cortical bone. Methods After 5 different storage periods (ranging from 0 to 12 months), goat femora and humeri were used to evaluate the effect of embalming and freezing on torsion, and on bending stiffness and strength. The effect on hardness and bone mineral density (BMD) was also evaluated. Results Even after 1 year, no statistically significant differences could be found in stiffness, strength, and energy absorption when we compared embalmed or frozen bones to a fresh reference group. In addition, although we found no significant change in BMD, there appears to be a tendency to increasing hardness. Interpretation We found that there was no effect on the mechanical properties of bone after storage periods of 1 year. We conclude that embalmed or frozen bones can safely be used for mechanical testing, at least for storage periods of up to one year.


  • Open Access

    The correlation between clinical, nuclear and histologic findings in a patient with Von Recklinghausen's disease

    by Justus-Martijn Brinkman, Johannes L Bron, Paul I J M Wuisman, Paul J van Diest, Emile F I Comans, Carla F M Molthoff

    Background: Malignant peripheral nerve sheath tumours (MPNST) are known to develop in patients with Neurofibromatosis type I (NF1) resulting in a decreased overall survival. The association between NF1 and the development of such MPNST has been investigated in detail. The biological behaviour however of multiple disseminated neurofibromas in patients with NF1 and the risk factors for malignant transformation remain unknown. Clinical signs are unreliable and additional imaging techniques are therefore required. Of such, positron emission tomography using [18F]-2-fluoro-2-deoxy-D-glucose (18FDG PET) is used to detect malignant changes in neurofibromas.Case presentation: A case is presented of a patient suffering from NF1 with clinical signs of malignant change and accumulation of18FDG in multiple neurofibromas. Histopathological examination of 20 lesions however, did not reveal any malignant features. There was no statistically significant relation between18FDG accumulation and malignant change, but rather with pain, size and growth.Conclusion: This case adds to the knowledge of the diverse biological behaviour of neurofibromas in patients with NF1


  • Evolving gene therapy approaches for osteosarcoma using viral vectors: Review

    by M.A. Witlox, M.L. Lamfers, P.I.J.M. Wuisman, D.T. Curiel, G.P. Siegal


  • Open Access

    High rate of failure of impaction grafting in large acetabular defects

    by E. H. van Haaren, I. C. Heyligers, F. G. M. Alexander, P. I. J. M. Wuisman

    We reviewed the results of 71 revisions of the acetabular component in total hip replacement, using impaction of bone allograft. The mean follow-up was 7.2 years (1.6 to 9.7). All patients were assessed according to the American Academy of Orthopedic Surgeons (AAOS) classification of bone loss, the amount of bone graft required, thickness of the graft layer, signs of graft incorporation and use of augmentation. A total of 20 acetabular components required re-revision for aseptic loosening, giving an overall survival of 72% (95% CI, 54.4 to 80.5). Of these failures, 14 (70%) had an AAOS type III or IV bone defect. In the failed group, poor radiological and histological graft incorporation was seen. These results suggest that impaction allografting in acetabular revision with severe bone defects may have poorer results than have previously been reported.


  • Radiographic, Histologic, and Chemical Evaluation of Bioresorbable 70/30 Poly-L-lactide-CO-D, L-lactide Interbody Fusion Cages in a Goat Model

    by Matthijs R. Krijnen, Margriet G. Mullender, Theo H. Smit, Vincent Everts, Paul I. J. M. Wuisman

    Study Design. A study of lumbar interbody fusion using polylactic acid-based bioresorbable fusion cages in a goat model. Objective. To evaluate the effect of polylactic acid polymer composition, and internal stabilization on the rate and quality of interbody fusion. Summary of Background Data. A spinal cage should provide an appropriate biomechanical environment to facilitate interbody fusion. Previous studies have shown that bioresorbable polylactic acid-based cages can provide adequate stability for spinal fusion. However, at present and to our knowledge, the best bioresorbable materials, optimal cage stiffness, and desired period over which the cage should biodegrade are unknown. Methods. Interbody fusions were performed at L3–L4 level in 35 skeletally mature Dutch milk goats. Titanium and poly-L-lactide-CO-D,L-lactide (PLDLLA) cages were implanted at random as stand-alone cages. In addition, PLDLLA cages were implanted with anterior fixation. The goats were euthanized at 3, 6, or 12 months. Radiographic, magnetic resonance imaging, histologic, and histomorphometric analyses were performed on retrieved segments. Chemical analysis was used to assess degradation of the retrieved PLDLLA cages. Beforehand, chemical and mechanical degradation of the PLDLLA cages were assessed in vitro. Results. At 3 months, bone graft was almost completely remodeled. Endochondral bone formation was observed in all specimens. At 6 months, 50% of the PLDLLA stand-alone cages and 83% of the PLDLLA anterior fixation cages were fused. At 12 months, 38% of the PLDLLA stand-alone and 83% of the titanium cages realized fusion. A very mild and dispersed foreign body reaction was seen in all PLDLLA specimens. E-beam sterilized PLDLLA cages degraded more rapidly in vivo as compared to both, PLDLLA cages in vitro, and ethylene oxide sterilized poly-L-lactic acid cages in vivo. Conclusions. Within the 3—6-month period, PLDLLA stand-alone cages provided insufficient mechanical stability, which manifested as cracking and deformation of the cages and lower fusion rates. This result implies that within this time, additional stabilization is required; supplemental internal fixation proved sufficient to obtain successful fusion. In all cases, only a mild host response was seen, indicating good biocompatibility.


  • Open Access

    In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile

    by Hein P Stallmann, Chris Faber, Antonius Ljj Bronckers, Arie V Nieuw Amerongen, Paul Ijm Wuisman

    Background: Polymethyl-methacrylate (PMMA) beads releasing antibiotics are used extensively to treat osteomyelitis, but require surgical removal afterwards because they do not degrade. Methods: As an alternative option, this report compares the in vitro gentamicin release profile from clinically used, biodegradable carrier-materials: six injectable cements and six granule-types. Cement cylinders and coated granules containing 3% gentamicin were submerged in dH2O and placed in a 48-sample parallel drug-release system. At regular intervals (30, 90, 180 min. and then every 24 h, for 21 days), the release fluid was exchanged and the gentamicin concentration was measured. The activity of released gentamicin was tested on Staphylococcus aureus. Results: All combinations showed initial burst-release of active gentamicin, two cements had continuous-release (17 days). The relative release of all cements (36–85%) and granules (30–62%) was higher than previously reported for injectable PMMA-cements (up to 17%) and comparable to other biodegradable carriers. From the cements residual gentamicin could be extracted, whereas the granules released all gentamicin that had adhered to the surface. Conclusion: The high release achieved shows great promise for clinical application of these biodegradable drug-carriers. Using the appropriate combination, the required release profile (burst or sustained) may be achieved.


  • Bioresorbable polymers: heading for a new generation of spinal cages

    by P. I. J. M. Wuisman, T. H. Smit

    The use of polymer-based bioresorbable materials is now expanding to the realm of spinal interbody fusion. Bioresorbable polymers have important advantages over metals, because they are temporary, much less stiff, and radiolucent. Most promising is a group of α-polyesters, in particular polylactide acids (PLAs). Their biocompatibility is excellent, and they have sufficient stiffness and strength to provide initial and intermediate-term stability required for bone healing. However, polylactides have characteristics that make them vulnerable to complications if not properly controlled. Degradation rate strongly depends on polymer type, impurities, manufacturing process, sterilization, device size, and the local environment. The fact that larger implants degrade faster is contra-intuitive, and should be considered in the design process. Also optimal surgical techniques, such as careful bone bed preparation, are required for a successful application of these materials. The purpose of this paper is to highlight the specific properties of these bioresorbable polymers and to discuss their potential and limitations. This is illustrated with early preclinical and clinical data. Bioresorbable cage technology is just emerging: their time-engineered degradation characteristics allow controlled dynamization in interbody applications, facilitating spinal fusion. Their radiolucency improves image assessment of fusion healing. Acceptance and use of bioresorbable implants may increase as further research and clinical studies report on their safety, efficacy, and proper usage.